XENE Stock Analysis Today

Updated Nov 12, 2026 · trends, key levels, insider activity and news

$42.10+$0.71 (+1.72%)close Nov 11, 2026

Is XENE bullish or bearish today?

Daily trend: Downtrend (confirmed) — turns up above $39.92

SEPT signal: Distribution · Strong Bullish

Research grade: B · fair value $67.00 (+59.1%)

XENE trend by timeframe

DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bullish

Trends are calculated from price structure and update during market hours.

XENE support and resistance levels

Resistance (above)

$43.665 touches

$46.993 touches

$50.912 touches

Support (below)

$41.054 touches

$39.588 touches

$37.153 touches

Upside zones: $47.74 / $49.18 / $50.62

See all levels on the live chart →

Insider and institutional activity

Insiders

Sell

30-day buys / sells

2 / 4

30-day net

—

Hedge fund holders

281

Latest XENE news and filings

  • EarningsFiscal.ai

    Xenon Pharmaceuticals Posts Q3 2026 Results

    The biopharma company shared its quarterly financial figures for the period ended in 2026, alongside an update on its business. The release covers its latest earnings and recent corporate developments.

  • EarningsBenzinga

    Xenon Pharmaceuticals holds Q3 2026 earnings call

    Xenon Pharmaceuticals discussed its third-quarter 2026 results on an earnings call. The call covered the company's quarterly performance.

  • SEC FilingSEC
    Xenon Pharmaceuticals Inc. filed a report on a major company event (Form 8-K)

    Form 8-K tells shareholders about important events such as deals, leadership changes or results.

  • EarningsBenzinga

    Xenon Pharmaceuticals reports Q3 loss of $1.11 per share, beating $1.13 estimate

    Xenon Pharmaceuticals posted a quarterly loss of $1.11 per share, which was smaller than the $1.13 loss analysts expected. The result beat the consensus estimate.

All XENE news from the last 90 days →
SEPT Investing$29.99/mo

Live XENE chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.

Start free 7-day trial

Frequently asked questions

Why did XENE stock move on Nov 9, 2026?

Nov 9, 2026: Xenon Pharmaceuticals shares closed at $40.45, up 1.81% on volume of about 1.48 million shares, after the company reported a third-quarter loss of $1.11 per share that beat the $1.13 consensus estimate. The stock traded between a low of $38.59 and a high of $40.52 during the session.

Is XENE bullish or bearish today?

XENE daily trend: Downtrend (confirmed) — turns up above $39.92. SEPT signal: Distribution (Strong Bullish). Updated Nov 12, 2026.

What is XENE's trend on each timeframe?

Daily: Downtrend (confirmed); 4 hour: Strong Bullish; 1 hour: Strong Bullish; 15 min: Strong Bullish; 5 min: Strong Bullish.

What are XENE support and resistance levels?

Support: $41.05, $39.58, $37.15. Resistance: $43.66, $46.99, $50.91. Last price $42.10.

Are insiders buying or selling XENE?

Insider signal: Sell. Last 30 days: 2 buys, 4 sells. 281 hedge funds hold XENE.

What is the latest news on XENE?

Nov 9, 2026: Xenon Pharmaceuticals Posts Q3 2026 Results · Nov 9, 2026: Xenon Pharmaceuticals holds Q3 2026 earnings call · Nov 9, 2026: Xenon Pharmaceuticals Inc. filed a report on a major company event (Form 8-K)